BODI
The Beachbody Company, Inc.
BODI trails on the overall score without a compensating advantage in the available component scores.
TMUS
T-Mobile US, Inc.
TMUS has the edge over BODI overall, supported by lower modeled downside and stronger valuation.
BODI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Under pressure | |
| Strong |
BODI's profitability and balance sheet are currently healthy, but its revenue and cash flow are under pressure.
TMUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
BODI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 2.1x | $3.25 | — |
| Cheap | 2.6x | $4.11 | +27% |
| Fair | 4.1x | $6.41 | +97% |
| Expensive | 15x | $22.97 | +607% |
Historical ranges are pointers, not guarantees.
BODI has the edge over TMUS in the historical PE scenario, which offers more potential upside but is not a forecast.
TMUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $171 | — |
| Current | 16x | $171 | — |
| Cheap | 21x | $218 | +27% |
| Fair | 26x | $274 | +60% |
| Expensive | 56x | $581 | +240% |
Historical ranges are pointers, not guarantees.
TMUS's PE is in its cheap range at 16x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
BODI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| Improving | |
| Limited | |
| Low |
Analysts expect BODI's losses to shrink, with revenue declining. However, they disagree widely on these estimates.
TMUS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
TMUS has the edge over BODI on the outlook, with more favorable revenue expectations.
BODI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.56 | +$7.81 |
| Q2 2026 | $1.69 | +$10.20 |
| Q1 2026 | $0.73 | +$9.98 |
| Q4 2025 | -$0.41 | +$10.10 |
| Q3 2025 | -$6.25 | +$9.66 |
| Q2 2025 | -$8.51 | +$11.15 |
| Q1 2025 | -$9.25 | +$12.82 |
| Q4 2024 | -$10.51 | +$13.96 |
BODI has the edge over TMUS on earnings, with more consistent year-over-year improvement.
TMUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.49 | +30% |
| Q3 2026 | $10.37 | -0.2% |
| Q2 2026 | $9.56 | -9.7% |
| Q1 2026 | $9.41 | -8.1% |
| Q4 2025 | $9.72 | +0.6% |
| Q3 2025 | $10.39 | +18% |
| Q2 2025 | $10.59 | +33% |
| Q1 2025 | $10.24 | +39% |
| Q4 2024 | $9.66 | +39% |
TMUS earned $10.37 per share over the past year, about the same as the year before.
BODI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $45.2M | -25% |
| Q2 2026 | $49.6M | -22% |
| Q1 2026 | $54.3M | -25% |
| Q4 2025 | $55.5M | -36% |
| Q3 2025 | $59.9M | -41% |
| Q2 2025 | $63.9M | -42% |
| Q1 2025 | $72.4M | -40% |
| Q4 2024 | $86.4M | -27% |
BODI's revenue has slid since its 2020 peak: $45M last quarter, down 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -5.4 points |
| Q2 2026 | 3.4% | +9.6 points |
| Q1 2026 | 5.7% | +11 points |
| Q4 2025 | 15% | +53 points |
| Q3 2025 | 8.3% | +21 points |
| Q2 2025 | -6.2% | +2.4 points |
| Q1 2025 | -5.1% | +3.9 points |
| Q4 2024 | -38% | +13 points |
BODI's operating margin was 2.9% last quarter, down 5.4 points from the same quarter a year ago.
TMUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.6B | +7.4% |
| Q2 2026 | $22.8B | +7.9% |
| Q1 2026 | $23.1B | +11% |
| Q4 2025 | $24.3B | +11% |
| Q3 2025 | $22B | +8.9% |
| Q2 2025 | $21.1B | +6.9% |
| Q1 2025 | $20.9B | +6.6% |
| Q4 2024 | $21.9B | +6.8% |
TMUS has the edge over BODI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +3.4 points |
| Q2 2026 | 24% | -0.6 points |
| Q1 2026 | 19% | -3.5 points |
| Q4 2025 | 15% | -5.6 points |
| Q3 2025 | 21% | -3.2 points |
| Q2 2025 | 25% | +1.3 points |
| Q1 2025 | 23% | +2.6 points |
| Q4 2024 | 21% | +4 points |
TMUS has the edge over BODI on profitability, with a higher operating margin.
BODI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.4M | -171% |
| Q2 2026 | -$4M | -265% |
| Q1 2026 | -$1.7M | -205% |
| Q4 2025 | $4.3M | +$11.6M |
| Q3 2025 | $9M | +16881% |
| Q2 2025 | $2.4M | +$4.6M |
| Q1 2025 | $1.6M | -78% |
| Q4 2024 | -$7.3M | +$1.7M |
BODI has burned cash in most quarters: −$8M over the past year, against $6M the year before.
TMUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +5.3% |
| Q2 2026 | $4.8B | +4.4% |
| Q1 2026 | $4.6B | +4.6% |
| Q4 2025 | $4.2B | +25% |
| Q3 2025 | $4.8B | +15% |
| Q2 2025 | $4.6B | +32% |
| Q1 2025 | $4.4B | +79% |
| Q4 2024 | $3.3B | +2% |
TMUS has the edge over BODI on cash generation, producing positive trailing cash flow while its opponent burns cash.
BODI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -6.2% | -487K shares |
| 1 year | +5.3% | +372K shares |
| 3 years | +20% | +1.2M shares |
| 5 years | +22% | +1.3M shares |
BODI has 7M diluted shares, up 5.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
TMUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -10.8M shares |
| 1 year | -4.9% | -55M shares |
| 3 years | -8.8% | -103M shares |
| 5 years | -15% | -182M shares |
| Available history | +24% | +207M shares |
TMUS has the edge over BODI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4B |
| Q2 2026 | $2.3B |
| Q1 2026 | $4.8B |
| Q4 2025 | $2.4B |
| Q3 2025 | $2.5B |
| Q2 2025 | $2.6B |
| Q1 2025 | $2.5B |
| Q4 2024 | $4.7B |
TMUS spent $12B buying back its own shares over the past year, down 1.7% from the year before.
BODI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2020 | -1.0x | Net Cash |
BODI has the edge over TMUS on leverage, with a lower net debt burden relative to earnings.
TMUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.4x | Moderate |
TMUS's net debt is less than a year of its operating earnings (EBITDA).
BODI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.4 | Oversold |
| Stochastic | 2.2 | Oversold |
BODI's weekly RSI is 29 (oversold) and its Stochastic is 2 (oversold).
TMUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 42.1 | Neutral |
TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).
BODI PE vs Communication Services Sector
| Metric | BODI | Sector median | Relative |
|---|---|---|---|
| PE | 2.1x | 16x | 87% below |
| PE % | 0 | 28 | 28 pts below |
BODI has the edge over TMUS on valuation relative to its sector.
TMUS PE vs Communication Services Sector
| Metric | TMUS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 16x | Same PE |
| PE % | 1 | 26 | 25 pts below |
TMUS is trading at 16x earnings, in line with the Communication Services sector's median of 16x.
BODI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.31 | 25% below |
| 20 week MA | $6.65 | 51% below |
| 50 week MA | $9.06 | 64% below |
| 100 week MA | $7.32 | 56% below |
| 200 week MA | $10.8 | 70% below |
BODI is in a downtrend: it's below all five of its weekly moving averages, and 70% below its 200-week average.
TMUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 7.5% above |
| 20 week MA | $172.0 | 0.5% below |
| 50 week MA | $187.8 | 8.9% below |
| 100 week MA | $212.9 | 20% below |
| 200 week MA | $188.7 | 9.4% below |
TMUS has the edge over BODI on trend strength, trading above more of its moving averages.
BODI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $523.5 | $126.0 | -76% |
| 2022 | $126.0 | $27.3 | -78% |
| 2023 | $27.3 | $8.29 | -70% |
| 2024 | $8.29 | $6.07 | -27% |
| 2025 | $6.07 | $10.1 | +66% |
| 2026 YTD | $10.1 | $3.25 | -68% |
BODI has finished lower in four of the last five years. It's down 68% so far in 2026.
TMUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.2 | $132.9 | +72% |
| 2021 | $132.9 | $119.9 | -9.8% |
| 2022 | $119.9 | $140.0 | +17% |
| 2023 | $140.0 | $160.3 | +15% |
| 2024 | $160.3 | $223.0 | +39% |
| 2025 | $223.0 | $201.0 | -9.9% |
| 2026 YTD | $201.0 | $171.0 | -15% |
TMUS has the edge over BODI on returns for 2026, with the stronger performance.